Wegovy and Saxenda are FDA-approved specifically for weight management for individuals who meet BMI or weight-related health condition criteria
Bilchik, who was not involved in this research, commented it is extremely important because it shows that not only do GLP-1 agonists have an effect on weight loss, but there is a potential anticancer effect
(In May, Novo said oral semaglutide tablets were proving as effective in tests.) The medication tricks the body into feeling full, even after consuming a small amount of food, and lasts longer than the natural hormone, slowing the passage of food through the digestive system
But it has not eliminated it from the body
These FDA-approved medications are safe and can regulate appetite, lower blood sugar levels, and reduce cravings